All Stories

  1. Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer

    Article • Clinical and Experimental Pharmacology and Physiology, August 2017, Wiley

    Dr. Wannarasmi Ketchart

  2. plumbagin effects in endocrine resistant breast cancer

    Article • Phytotherapy Research, August 2016, Wiley

    Dr. Wannarasmi Ketchart